HLA-DRB1 and myeloid sarcoma: Additional studies in larger cohorts will be of importance to define MS among the patient group not associated with HLA‐DRB5*01:01:01‐DRB1*15:01:01‐DQA1*01:02:01‐DQB1*06:02:01.